These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. The impact of overactive bladder, incontinence and other lower urinary tract symptoms on quality of life, work productivity, sexuality and emotional well-being in men and women: results from the EPIC study. Coyne KS, Sexton CC, Irwin DE, Kopp ZS, Kelleher CJ, Milsom I. BJU Int; 2008 Jun; 101(11):1388-95. PubMed ID: 18454794 [Abstract] [Full Text] [Related]
6. Prevalence, severity, and symptom bother of lower urinary tract symptoms among men in the EPIC study: impact of overactive bladder. Irwin DE, Milsom I, Kopp Z, Abrams P, Artibani W, Herschorn S. Eur Urol; 2009 Jul; 56(1):14-20. PubMed ID: 19278775 [Abstract] [Full Text] [Related]
7. Understanding the elements of overactive bladder: questions raised by the EPIC study. Irwin DE, Abrams P, Milsom I, Kopp Z, Reilly K, EPIC Study Group. BJU Int; 2008 Jun; 101(11):1381-7. PubMed ID: 18336602 [Abstract] [Full Text] [Related]
8. Prevalence of overactive bladder in China, Taiwan and South Korea: Results from a cross-sectional, population-based study. Chuang YC, Liu SP, Lee KS, Liao L, Wang J, Yoo TK, Chu R, Sumarsono B. Low Urin Tract Symptoms; 2019 Jan; 11(1):48-55. PubMed ID: 28967230 [Abstract] [Full Text] [Related]
10. Effect of bothersome overactive bladder symptoms on health-related quality of life, anxiety, depression, and treatment seeking in the United States: results from EpiLUTS. Milsom I, Kaplan SA, Coyne KS, Sexton CC, Kopp ZS. Urology; 2012 Jul; 80(1):90-6. PubMed ID: 22748867 [Abstract] [Full Text] [Related]
12. Prevalence and bother of lower urinary tract symptoms and overactive bladder in Poland, an Eastern European Study. Przydacz M, Golabek T, Dudek P, Lipinski M, Chlosta P. Sci Rep; 2020 Nov 13; 10(1):19819. PubMed ID: 33188254 [Abstract] [Full Text] [Related]
14. Mirabegron Add-on Therapy to Tamsulosin for the Treatment of Overactive Bladder in Men with Lower Urinary Tract Symptoms: A Randomized, Placebo-controlled Study (MATCH). Kakizaki H, Lee KS, Yamamoto O, Jong JJ, Katou D, Sumarsono B, Uno S, Yamaguchi O. Eur Urol Focus; 2020 Jul 15; 6(4):729-737. PubMed ID: 31718957 [Abstract] [Full Text] [Related]
15. Prevalence of overactive bladder, urinary incontinence, and lower urinary tract symptoms: results of Korean EPIC study. Lee YS, Lee KS, Jung JH, Han DH, Oh SJ, Seo JT, Lee JG, Park HS, Choo MS. World J Urol; 2011 Apr 15; 29(2):185-90. PubMed ID: 19898824 [Abstract] [Full Text] [Related]
16. The prevalence of lower urinary tract symptoms (LUTS) and overactive bladder (OAB) by racial/ethnic group and age: results from OAB-POLL. Coyne KS, Sexton CC, Bell JA, Thompson CL, Dmochowski R, Bavendam T, Chen CI, Quentin Clemens J. Neurourol Urodyn; 2013 Mar 15; 32(3):230-7. PubMed ID: 22847394 [Abstract] [Full Text] [Related]
17. Add-on fesoterodine for residual storage symptoms suggestive of overactive bladder in men receiving α-blocker treatment for lower urinary tract symptoms. Kaplan SA, Roehrborn CG, Gong J, Sun F, Guan Z. BJU Int; 2012 Jun 15; 109(12):1831-40. PubMed ID: 21966995 [Abstract] [Full Text] [Related]
18. Prevalence and effect on health-related quality of life of overactive bladder in older americans: results from the epidemiology of lower urinary tract symptoms study. Sexton CC, Coyne KS, Thompson C, Bavendam T, Chen CI, Markland A. J Am Geriatr Soc; 2011 Aug 15; 59(8):1465-70. PubMed ID: 21718275 [Abstract] [Full Text] [Related]
19. Overactive bladder symptom severity, bother, help-seeking behavior, and quality of life in patients with type 2 diabetes: a path analysis. Xu D, Zhao M, Huang L, Wang K. Health Qual Life Outcomes; 2018 Jan 02; 16(1):1. PubMed ID: 29291738 [Abstract] [Full Text] [Related]
20. Association between occupational stress and risk of overactive bladder and other lower urinary tract symptoms: a cross-sectional study of female nurses in China. Zhang C, Hai T, Yu L, Liu S, Li Q, Zhang X, Xu T, Wang X. Neurourol Urodyn; 2013 Mar 02; 32(3):254-60. PubMed ID: 22903277 [Abstract] [Full Text] [Related] Page: [Next] [New Search]